MGS, a global contract development and manufacturing organization (CDMO), has officially integrated Technolution into the MGS brand to reinforce the company’s ability to accelerate healthcare innovations for Pharmaceutical, Diagnostic and MedTech customers around the world.
The move reflects a growing trend in the medical device space: the need for true end-to-end partners who can bridge the gap between early product vision and global market realization. The companies first joined forces in 2023, recognizing a need to support MGS’ existing capabilities in tooling, automation and manufacturing with even earlier design expertise. This framework enables MGS to create a seamless, vertically integrated value chain focused on reducing risk, accelerating timelines and improving patient outcomes.
With decades of experience supporting breakthrough drug device development, the MGS Design & Development team brings critical early-phase expertise that lays the foundation for scalable manufacturing. Its multidisciplinary capabilities span human-centered design, usability engineering, mechanical and sustainability engineering, simulation and modeling, all supported by in-house quality, regulatory affairs and project management functions. This breadth of knowledge is essential for managing the increasing technical and regulatory complexity of modern devices, ensuring alignment across disciplines to support scalability, compliance and speed.
Whether providing targeted support for a specific design competency or leading full-scale development, the Design & Development team works closely with customers to solve high-stakes challenges at the intersection of technology, user experience and clinical performance. By applying a development-first mindset early in the process, it helps streamline decision-making, improve manufacturability and ensure that products meet real-world performance and market expectations.
“Our Design & Development team has always brought curiosity, creativity and precision to the front end of product development and innovation,” said Paul Manley, President & CEO of MGS. “Across all of MGS’ global teams, we share a commitment to solving complex challenges with speed and care. Now, as one brand, we’re making that expertise even more accessible by connecting it across the full product lifecycle.”
“We are proud to bring our design and development expertise more fully into the MGS brand,” said Thomas Bach Agerslev, Vice President of MGS Design & Development and former CEO of Technolution. “Our team is still the same approachable, high-performing group of people our clients know – curious, collaborative and, yes, still nice and nerdy. This change reflects how we already work and makes it even easier for customers to access our end-to-end solutions closer to where they do business.”
For today’s healthcare innovators, the challenge isn’t just developing breakthrough products. It’s doing so faster, at scale and in alignment with complex regulatory requirements and diverse patient needs. MGS meets this challenge through a globally connected, end-to-end model that aligns early design and development with in-house tooling, custom automation and advanced manufacturing. With cross-functional teams engaged from the outset, MGS reduces delays, prevents costly redesigns and ensures that what’s developed meets clinical expectations, supports patient usability and delivers consistent performance across patient needs.
With primary operations based in Hørsholm, Denmark, and an expanded presence in Boston, USA, the MGS Design & Development team is strategically positioned to collaborate with MGS customers across North America and Europe.
The brand integration marks another milestone in MGS’ long-term strategy to offer integrated global solutions that help healthcare innovators move faster, de-risk development, scale smarter and bring life-changing solutions to market with greater confidence.
